Ann Lab Med.  2023 Sep;43(5):508-511. 10.3343/alm.2023.43.5.508.

Evaluation of the AdvanSure One-Stop COVID-19 Plus Kit for SARS-CoV-2 Detection Using a Streamlined RNA Extraction Method

Affiliations
  • 1Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
  • 2Center for Clinical Medicine, Samsung Biomedical Research Institute, Samsung Medical Center, Seoul, Korea
  • 3Biomedical Engineering Research Center, Smart Healthcare Research Institute, Samsung Medical Center, Seoul, Korea
  • 4Department of Medical Device Management and Research, Samsung Advanced Institute for Health Sciences & Technology, Sungkyunkwan University, Seoul, Korea

Abstract

Real-time reverse transcription (rRT)-PCR, which is the reference standard for the diagnosis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, generally involves a time-consuming and costly RNA extraction step prior to amplification. We evaluated the performance of the AdvanSure One-Stop COVID-19 Plus Kit (LG Chem, Seoul, Korea), a novel rRT-PCR assay that can detect SARS-CoV-2 within 90 minutes using a streamlined RNA extraction method. In total, 509 nasopharyngeal swab (NPS) specimens (SARS-CoV-2 positive: N=205; SARS-CoV-2 negative: N=304) previously tested using the PowerChek SARS-CoV-2 Real-time PCR Kit (Kogene Biotech, Seoul, Korea) were tested using the AdvanSure assay. The limit of detection (LOD) of the AdvanSure assay was determined using serially diluted inactivated SARS-CoV-2. The positive and negative percent agreements between the AdvanSure and PowerChek assays were 99.5% (204/205) and 99.3% (302/304), respectively. The LODs of the AdvanSure assay for SARS-CoV-2 nucleocapsid and spike/RNA-dependent RNA polymerase genes were 672 and 846 copies/mL, respectively. The results show that the performance of the AdvanSure assay is comparable to that of the PowerChek assay used for routine SARS-CoV-2 testing, suggesting that the AdvanSure assay is a useful diagnostic tool for rapid and accurate detection of SARS-CoV-2 infection.

Keyword

AdvanSure; COVID-19; SARS-CoV-2; RNA extraction; Real-time reverse transcription PCR; Performance

Reference

1. Sung H, Roh KH, Hong KH, Seong MW, Ryoo N, Kim HS, et al. 2020; COVID-19 molecular testing in Korea: practical essentials and answers from experts based on experiences of emergency use authorization assays. Ann Lab Med. 40:439–47. DOI: 10.3343/alm.2020.40.6.439. PMID: 32539299. PMCID: PMC7295959.
Article
2. Hong KH, Kim GJ, Roh KH, Sung H, Lee J, Kim SY, et al. 2022; Update of guidelines for laboratory diagnosis of COVID-19 in Korea. Ann Lab Med. 42:391–7. DOI: 10.3343/alm.2022.42.4.391. PMID: 35177559. PMCID: PMC8859556.
Article
3. Kriegova E, Fillerova R, Kvapil P. 2020; Direct-RT-qPCR detection of SARS-CoV-2 without RNA extraction as part of a COVID-19 testing strategy: from sample to result in one hour. Diagnostics (Basel). 10:605. DOI: 10.3390/diagnostics10080605. PMID: 32824767. PMCID: PMC7459950.
Article
4. Delgado-Diaz DJ, Sakthivel D, Nguyen HHT, Farrokzhad K, Hopper W, Narh CA, et al. 2022; Strategies that facilitate extraction-free SARS-CoV-2 nucleic acid amplification tests. Viruses. 14:1311. DOI: 10.3390/v14061311. PMID: 35746782. PMCID: PMC9230587.
Article
5. Fomsgaard AS, Rosenstierne MW. 2020; An alternative workflow for molecular detection of SARS-CoV-2-escape from the NA extraction kit-shortage, Copenhagen, Denmark, March 2020. Euro Surveill. 25:2000398. DOI: 10.2807/1560-7917.ES.2020.25.14.2000398. PMID: 32290902. PMCID: PMC7160440.
Article
6. Liotti FM, Menchinelli G, Marchetti S, Morandotti GA, Sanguinetti M, Posteraro B, et al. 2020; Evaluating the newly developed BioFire COVID-19 test for SARS-CoV-2 molecular detection. Clin Microbiol Infect. 26:1699–700. DOI: 10.1016/j.cmi.2020.07.026. PMID: 32735938. PMCID: PMC7385983.
Article
7. Barza R, Patel P, Sabatini L, Singh K. 2020; Use of a simplified sample processing step without RNA extraction for direct SARS-CoV-2 RT-PCR detection. J Clin Virol. 132:104587. DOI: 10.1016/j.jcv.2020.104587. PMID: 32898817. PMCID: PMC7418644.
Article
8. Hasan MR, Mirza F, Al-Hail H, Sundararaju S, Xaba T, Iqbal M, et al. 2020; Detection of SARS-CoV-2 RNA by direct RT-qPCR on nasopharyngeal specimens without extraction of viral RNA. PLoS One. 15:e0236564. DOI: 10.1371/journal.pone.0236564. PMID: 32706827. PMCID: PMC7380591.
Article
9. Mancini F, Barbanti F, Scaturro M, Errico G, Iacobino A, Bella A, et al. 2020; Laboratory management for SARS-CoV-2 detection: a user-friendly combination of the heat treatment approach and rt-real-time PCR testing. Emerg Microbes Infect. 9:1393–6. DOI: 10.1080/22221751.2020.1775500. PMID: 32552549. PMCID: PMC7473159.
Article
10. Merindol N, Pépin G, Marchand C, Rheault M, Peterson C, Poirier A, et al. 2020; SARS-CoV-2 detection by direct rRT-PCR without RNA extraction. J Clin Virol. 128:104423. DOI: 10.1016/j.jcv.2020.104423. PMID: 32416598. PMCID: PMC7204723.
Article
11. Blairon L, Piteüs S, Beukinga I, Tré-Hardy M. 2021; Development and implementation of a RT-qPCR extraction-free protocol for the detection of SARS-CoV-2 and impact on the turn-around-time. J Med Virol. 93:2538–42. DOI: 10.1002/jmv.26782. PMID: 33415765.
Article
12. Garcia-Venzor A, Rueda-Zarazua B, Marquez-Garcia E, Maldonado V, Moncada-Morales A, Olivera H, et al. 2021; SARS-CoV-2 direct detection without RNA isolation with loop-mediated isothermal amplification (LAMP) and CRISPR-Cas12. Front Med (Lausanne). 8:627679. DOI: 10.3389/fmed.2021.627679. PMID: 33681254. PMCID: PMC7928313.
Article
13. Genoud V, Stortz M, Waisman A, Berardino BG, Verneri P, Dansey V, et al. 2021; Extraction-free protocol combining proteinase K and heat inactivation for detection of SARS-CoV-2 by RT-qPCR. PLoS One. 16:e0247792. DOI: 10.1371/journal.pone.0247792. PMID: 33635936. PMCID: PMC7909620.
Article
14. Guan B, Frank KM, Maldonado JO, Beach M, Pelayo E, Warner BM, et al. 2021; Sensitive extraction-free SARS-CoV-2 RNA virus detection using a chelating resin. iScience. 24:102960. DOI: 10.1016/j.isci.2021.102960. PMID: 34396082. PMCID: PMC8349732.
Article
15. Mallmann L, Hermann BS, Schallenberger K, Demoliner M, Eisen AKA, Heldt FH, et al. 2021; Proteinase K treatment in absence of RNA isolation classical procedures is a quick and cheaper alternative for SARS-CoV-2 molecular detection. J Virol Methods. 293:114131. DOI: 10.1016/j.jviromet.2021.114131. PMID: 33798606. PMCID: PMC8008826.
Article
16. Naranbat D, Schneider L, Kantor R, Beckwith CG, Bazerman L, Gillani F, et al. 2022; DirectDetect SARS-CoV-2 direct real-time RT-PCR study using patient samples. ACS Omega. 7:4945–55. DOI: 10.1021/acsomega.1c05595. PMID: 35187313. PMCID: PMC8845437.
Article
17. Safiabadi Tali SH, LeBlanc JJ, Sadiq Z, Oyewunmi OD, Camargo C, Nikpour B, et al. 2021; Tools and techniques for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)/COVID-19 detection. Clin Microbiol Rev. 34:e000228–20. DOI: 10.1128/CMR.00228-20. PMID: 33980687. PMCID: PMC8142517.
Article
18. Loeffelholz MJ, Alland D, Butler-Wu SM, Pandey U, Perno CF, Nava A, et al. 2020; Multicenter evaluation of the Cepheid Xpert Xpress SARS-CoV-2 test. J Clin Microbiol. 58:e00926–20. DOI: 10.1128/JCM.00926-20. PMID: 32366669. PMCID: PMC7383535.
Article
Full Text Links
  • ALM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr